VPH is an international community driving the adoption of in silico medicine by connecting scientists, industry, clinicians, patients, healthcare providers, regulators, and policymakers for a better and more efficient healthcare.
Countries involved
Institutions involved
Members
Discover more
The VPH 2026 Conference was a celebration not only of scientific advances, but also of the people driving the future of in silico medicine. During the Awards Ceremony in Milan, we recognised outstanding contributions from early-career researchers across our community, celebrating their research, creativity and commitment to advancing the field.
It is with great sadness that we mourn the passing of Professor Reinhard Schneider, a distinguished scientist, colleague and valued member of the VPH Community.
From media coverage and patient engagement to clinician adoption, VPH team members will present new studies exploring the societal, ethical, and communication challenges shaping the future of in silico medicine.
